-
Sector Analysis
NewOsteoporosis Epidemiology Analysis and Forecast to 2033
Osteoporosis Report Overview In the 7MM, there were 20,291,551 diagnosed prevalent cases of osteoporosis in 2023. The diagnosed prevalent cases of osteoporosis will register an AGR of more than 1% during 2023-2033. Osteoporosis is a disease in which the density and quality of bone are reduced over time. In a normal process known as remodeling, some of a person’s bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteoporosis, bone loss outpaces the growth of...
-
Product Insights
NewVirpax Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Virpax Pharmaceuticals Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Virpax Pharmaceuticals Inc (Virpax) is a Pharmaceutical company. Its pipeline product portfolio includes DSF100, metered dose spray film for the treatment of musculoskeletal pain; LBL100, a liposomal-gel used in post-surgical knee and hip pain; NES100, an intranasal spray to treat chronic pain; and Epoladerm, a Metered-based spray film for the treatment of chronic osteoarthritis of the knee. It utilizes...
-
Product Insights
Likelihood of Approval Analysis for Polymyalgia Rheumatica (PMR)
Overview How likely is it that the drugs in Polymyalgia Rheumatica (PMR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polymyalgia Rheumatica (PMR) Overview Polymyalgia rheumatica (PMR) is a rheumatic disorder...
-
Product Insights
NewMeril Life Sciences Pvt Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Meril Life Sciences Pvt Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Meril Life Sciences Pvt Ltd (Meril) is a company that designs, develops and manufactures medical devices. It offers vascular intervention devices such as stents, scaffolds, catheters, inflation and vascular closure devices; and orthopedic implants such as knee and hip replacement systems and instrument sets. Its diagnostic product range includes analyzers, reagents for clinical biochemistry, haematology, immunology, rapids,...
-
Product Insights
NewSmith & Nephew Plc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Smith & Nephew Plc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Smith & Nephew Plc (Smith & Nephew) is a medical technology company that is engaged in the development, manufacturing and marketing of medical devices for use in orthopaedic reconstruction and trauma, sports medicine, ENT and advanced wound management. The company offers knee and hip implants to replace diseased, damaged or worn joints; robotics-assisted enabling technologies; and trauma products...
-
Product Insights
Likelihood of Approval Analysis for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Overview How likely is it that the drugs in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Arterial Disease (PAD)/ Peripheral Vascular...
-
Product Insights
Likelihood of Approval Analysis for Osteoarthritis Pain
Overview How likely is it that the drugs in Osteoarthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Osteoarthritis Pain Overview Osteoarthritis pain, the hallmark symptom of this degenerative joint...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HB-adMSCs in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HB-adMSCs in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HB-adMSCs in Rheumatoid Arthritis Drug Details: Cell therapy is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abobotulinumtoxina in Migraine
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abobotulinumtoxina in Migraine report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abobotulinumtoxina in Migraine Drug Details: Abobotulinumtoxin A (Dysport, Botulinum Toxin Type A, Azzalure)...